Innovation Pharmaceuticals Inc. IPIX
0.00 USD 0.00 (+0.00%)
At closeNov 2, 2026, 4:00 PM EST
0.0007 Day range 0.012
0.0001 52-week range 0.05
- YTD
- -80.00%
- 1 year
- -80.00%
- Market cap
- 103.67K
- EPS (ttm)
- -0.01
- YTD return
- -80.00%
- 1-year return
- -80.00%
- Volume
- 12.60K
- Avg volume
- 274.89K
- Open
- 0.012
- Previous close
- 0.0002
- Day's range
- 0.0007 – 0.012
- 52-week range
- 0.0001 – 0.05
2Y -0.0003 (-60.00%)
News
Innovation X Advisors Participates in Shield AI's $1.5 Billion Series G Financing 
AdvanCell Signs 128,000 Square Foot, Full Building Lease at IQHQ's Innovation Park in Andover, Massachusetts 
INVNT™ Announced as Sponsor and Co-Producer of Discovery Stage at SXSW Sydney® 2024 
Innovation Pharmaceuticals Announces New Milestone at BeaMed; On Track to File 510(k) Submission to FDA in Q2 2024 
Innovation Pharma Announces New Brilacidin Antiviral Research on Non-SARS-CoV-2 Endemic Viral Diseases to be Presented at the 2021 Military Health System Research Symposium 
Patient Enrollment Reaches 90 Percent in Innovation Pharmaceuticals Phase 2 Clinical Trial of Brilacidin for COVID-19 
Innovation Pharma Surpasses 50 Percent Enrollment in Phase 2 Clinical Trial of Brilacidin for COVID-19 
Innovation Pharma's Broad Spectrum Antiviral Drug Candidate Brilacidin Highlighted in Biodefense and Infectious Diseases COVID-19 Presentation 
Innovation Pharma Announces Brilacidin Abstract Accepted for Oral Presentation at the American Society for Virology's Annual Meeting 
Innovation Pharma Completes Interim Safety Data Review—DMC Approves Increased Dosing Frequency in Phase 2 Clinical Trial of Brilacidin in Hospitalized COVID-19 Patients
Your note
Sign in to keep a note on IPIX — it syncs with the Stock Master app.